FDA Identifies Excipients At Risk for Potential Melamine Contamination; Issues Alert That New USP Standards for Heparin Products Will Result in Decreased Potency
This article was originally published in PharmAsia News
Executive Summary
FDA officials have alerted pharmaceutical manufacturers and suppliers of 23 drug excipients that may be at risk for melamine contamination and outlined certain compendial and non-compendial procedures to follow for better detecting its presence
You may also be interested in...
A Year After Chinese Health Authorities Vow To Rid Country Of Deliberately Adulterated Milk, A New Melamine Scandal Surfaces
BEIJING - One year after 11 Chinese ministries unveiled a massive program to ensure that the poison melamine was purged from national milk supplies, details are emerging of a new scandal involving the toxic chemical, along with a new government-aided cover-up in the rich coastal city of Shanghai
A Year After Chinese Health Authorities Vow To Rid Country Of Deliberately Adulterated Milk, A New Melamine Scandal Surfaces
BEIJING - One year after 11 Chinese ministries unveiled a massive program to ensure that the poison melamine was purged from national milk supplies, details are emerging of a new scandal involving the toxic chemical, along with a new government-aided cover-up in the rich coastal city of Shanghai
China Releases New Edition Of Chinese Pharmacopeia, Bringing The Country One Step Closer To Global Standards
SHANGHAI - China's State FDA announced Oct. 10 that compilation of the new Chinese Pharmacopeia 2010 edition has been completed and will be implemented July 1, 2010. The new edition covers more than 4,600 kinds of medicines